Cutting the ribbon (from left to right): Trey Davis, City Manager, City of Greensboro; Tammi Thurm, Councilmember, City of Greensboro; Nancy Vaughan, Mayor, City of Greensboro; Ted Mosler, President, Sanner of US; Clayton Roberts, VP of Business Development, Sanner of US; Wade Stauffer, VP of Manufacturing – Components, Sanner of US; Christian Classen, Chief Sales Officer, Sanner Group; Chris Gilmor, VP of Business Development, Sanner of America; Brent Christensen, President, Greensboro Chamber of Commerce; Marvin Price, Vice President, Greensboro Chamber of Commerce
Sanner, a global leader in high-quality healthcare packaging and drug delivery solutions, officially opened its first U.S.-based injection molding facility in Greensboro, North Carolina, just weeks after commencing initial operations. This marks a strategic milestone in the company’s 134-year history: signaling a new era of innovation, customer proximity, and sustainable growth with localized production to better serve MedTech and pharmaceutical partners across North America.
“This is more than just a new facility,” said Christian Classen, CSO of Sanner Group. “It’s a bold step forward in our global journey, reinforcing our long-term commitment to supporting our customers in North America with local production, cutting-edge technology, and world-class service.”
Key highlights of the new facility:
- 60,500 sq ft site equipped with GMP-certified cleanrooms (ISO Class 7 & 8)
- Advanced injection molding
- High-speed desiccant filling
- State-of-the-art laboratory capabilities
- Designed for the future with 20,000 sq ft of expansion space built into the site
Sanner’s investment in Greensboro strengthens its position as a trusted supplier of quality-driven primary packaging and as Contract Development and Manufacturing Organization (CDMO) for the healthcare industry — seamlessly integrating global quality standards with local responsiveness.
By combining world-class design expertise with Gilero, as Sanner Group’s Design Center of Excellence in the U.S., local and global manufacturing capacity, regulatory insight, and operational excellence, Sanner helps its partners to not only navigate these challenges but to thrive within them. Whether launching a next-generation drug delivery combination device, an innovative diagnostic, a connected health device, or a pharmaceutical packaging to maintain physical and chemical stability, Sanner provides everything pharmaceutical companies need from a single source.
“We’re grateful for the warm welcome and outstanding support from the Greensboro community,” added Classen. “This new site is a testament to what’s possible when global vision meets local partnership. Today, Sanner opens the door to a new chapter: this time, in the U.S.”
With recent expansions in Germany, China, and now the United States, Sanner is well-positioned to support the evolving needs of healthcare customers around the world to bring innovative solutions closer to where they’re needed most.
About Sanner
Sanner GmbH was founded in 1894. Headquartered in Germany with best-in-class manufacturing facilities across Germany, France, Hungary, China, and the U.S., Sanner has successively developed from a global market leader for desiccant closures and effervescent tablet packaging into a sought-after provider of customized solutions in the areas of medical devices and diagnostics, pharmaceuticals, and consumer healthcare. Today, Sanner supplies its products to more than 150 countries globally and has more than 820 employees. In November 2021, GHO Capital, Europe’s leading specialist investor in healthcare, acquired a majority stake in Sanner to partner with the fourth generation of the Sanner family to continue to support the growth of the company with a specific focus on transforming Sanner into a global MedTech CDMO.
Media contact
Dan Webb
Marketing Communications Manager
Tel. +1 (919) 595 8241
dwebb@gilero.com